Sector News

Coronavirus tracker: Alexion launches trial; Lilly, BMS extend help; Trump offers to treat British PM

April 7, 2020
Life sciences

Two biopharmas, Alexion Pharmaceuticals and Karyopharm, are trialing possible treatments while Eli Lilly and Bristol Myers Squibb are offering to help the unemployed stay on their meds.

Meanwhile, President Donald Trump offered U.K. Prime MInister Boris Johnson, in the ICU with COVID-19, unproven treatments. And news emerged that Trump himself holds a small financial interest in Sanofi, which makes an off-patent brand of hydroxychloroquine.

India is reportedly retracting export bans on 13 active pharmaceutical ingredients and finished formulations, and hydroxychloroquine may be included.

As of Tuesday, the number of global confirmed cases had surpassed 1.36 million, according to Johns Hopkins University’s real-time dashboard, and nearly 76,000 people had died.

See all of FiercePharma’s COVID-19 coverage here

By Eric Sagonowsky, Kyle Blankenship, Angus Liu, Conor Hale

Source: Fierce Pharma

Related News

October 17, 2020

Ong leaves Biogen to become CEO-partner at Flagship

Life sciences

The appointment makes Tuyen Ong the latest in a series of new CEO-partners hired by Flagship. Flagship Pioneering has named Tuyen Ong as CEO-partner. The new role sees the ex-Biogen […]

October 17, 2020

Pharma, take note: Millennials plan to spend more on meds, study says

Life sciences

The COVID-19 pandemic has millennials worried—and that has them planning to buy more prescription drugs in the future, new research finds. WPP’s global media group, Mindshare, began surveying consumers in […]

October 17, 2020

AstraZeneca secures $486m from US for Covid-19 antibody

Life sciences

AstraZeneca has received an investment of approximately $486m from the US Government to develop and supply its long-acting antibody (LAAB) cocktail, AZD7442, for Covid-19 treatment. AstraZeneca has received an investment […]